unknown
Stage
1
Investors
About
Develops a new generation of sustainable, natural antibacterial solutions based on bacteriophages to target and control bacterial pathogens.
Explore MEDEA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.